Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) – possible lessons from a systematic review of SARS-CoV therapy
Open Access
- 31 October 2013
- journal article
- review article
- Published by Elsevier BV in International Journal of Infectious Diseases
- Vol. 17 (10), e792-e798
- https://doi.org/10.1016/j.ijid.2013.07.002
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- SARS: Systematic Review of Treatment EffectsPLoS Medicine, 2006
- Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospitalJournal of Antimicrobial Chemotherapy, 2005
- Use of convalescent plasma therapy in SARS patients in Hong KongEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003Tropical Medicine & International Health, 2004
- Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patientsClinical Microbiology & Infection, 2004
- Severe acute respiratory syndrome: report of treatment and outcome after a major outbreakThorax, 2004
- Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findingsThorax, 2004
- Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR ChinaJournal of Medical Microbiology, 2003
- Use of the Internet and E-mail for Health Care Information: Results From a National Survey--CorrectionJAMA, 2003
- Identification of Severe Acute Respiratory Syndrome in CanadaThe New England Journal of Medicine, 2003